USPatentGranted
S1

Drug delivery implement

Granted 17 Mar 2020 · no office action yet

Current assignee: Medimmune, Llc. · originally AstraZeneca

Law firm: Law firm · Log in to unlock

Attorney: Attorney · Log in to unlock

Inventors: Janardhanan Anand Subramony, Corbin Zean Clawson, Roger Wongjung Liu · Examiner: Nathan M Johnston · AU 2919 · TC 2900

Application
29/649,944
filed 4 Jun 2018
Publication
Not published
not published
Patent· this page
US D878564
granted 17 Mar 2020

Life of the patent

5 dated events
⤢ drag to zoom20182020202220242026202820302032203420362038ProsecutionTerm & fees
ProsecutionTerm & feeshover for detail · click to open

Description

1 parts
›FIG. 1 is a perspective view of an…

FIG. 1 is a perspective view of an ornamental design for a drug delivery implement showing our new design;

FIG. 2 is a front elevation view thereof; a rear elevation view being a mirror image thereof;

FIG. 3 is a left side elevation view thereof; a right side elevation view being a mirror image thereof;

FIG. 4 is a top plan view thereof;

FIG. 5 is a bottom plan view thereof; and,

FIG. 6 is a perspective view of FIG. 1 with a cap separated from the drug delivery implement.

The broken lines illustrate portions of the drug delivery implements with translucent housing and form no part of the claimed design.

the grant prints no section headings; every part label below is ours, taken from that part's own first words

Claims

1 · 1 independent · depth 1
1 granted claims

Classifications

1 codes
USPC · US Patent Classification
D24/113

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomJul 2018Oct 2018Jan 2019Apr 2019Jul 2019Oct 2019Jan 2020Apr 2020USPTOApplicantRestriction requirementNotice of allowance
USPTOApplicanthover for detail · click to open
Pendency
1.8 y
652 days filing → grant
Office actions
0
after a restriction
Examiner
Nathan M Johnston
art unit 2919 · TC 2900
Citations: 39 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Worldwide family

3 members · 2 offices
US2CA1
this patentIP5 & PCTother officessolid = grantedhover for detail · click to open
Members
3
DOCDB simple family 60953437
Offices
2
US
Granted
3 of 3
grant date present
›IP5 & PCT — 2 members
OfficePublicationKindPublishedFiledStatusTitle
USUS-D822199-SS13 Jul 201822 Jun 2016grantedDrug delivery implement
USthis patentUS-D878564-SS117 Mar 20204 Jun 2018grantedDrug delivery implement
›Other offices — 1 members
OfficePublicationKindPublishedFiledStatusTitle
CACA-171818-SS10 Jan 201825 Nov 2016grantedDrug delivery implement

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock